Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/GL9 stock hub

FRA/GL9 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/GL9is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/GL9

In the news

Latest news · FRA/GL9

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.2

P25 n/aP50 n/aP75 n/a

Trailing P/E30.2

P25 n/aP50 n/aP75 n/a

ROE9.2

P25 n/aP50 n/aP75 n/a

ROIC12

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/GL9 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Ireland
Country code	DE
Employees	4,963
Employees Change	257%
Employees Change Percent	4.64
Enterprise value	EUR 5.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 4.7B
Price	EUR 19.2
Price currency	EUR
Rev Per Employee	677,002.81x
Sic	2834
Symbol	fra/GL9
Website	https://www.glanbia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.31%
EV Earnings	33.66x
EV/EBIT	17.07x
EV/EBITDA	12.75x
EV/FCF	19.35x
EV/Sales	1.56x
FCF yield	5.76%
Forward P/E	15.24x
P/B ratio	2.87x
P/E ratio	30.19x
P/S ratio	1.4x
PE Ratio10 Y	18.59x
PE Ratio3 Y	23.06x
PE Ratio5 Y	19.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.88%
EBITDA Margin	11.45%
FCF margin	8.08%
Gross margin	26.9%
Gross Profit	EUR 903.8M
Gross Profit Growth	-2.33%
Gross Profit Growth Q	-4.51%
Gross Profit Growth3 Y	-3.02%
Gross Profit Growth5 Y	0.74%
Net Income	EUR 156.1M
Net Income Growth	11.29%
Net Income Growth Q	292.06%
Net Income Growth3 Y	-16.89%
Net Income Growth5 Y	-7.55%
Pretax Margin	5.3%
Profit Margin	4.64%
Profit Per Employee	EUR 31,445
ROA	5.58
Roa5y	5.31
ROCE	12.71
ROE	9.17
Roe5y	10.64
ROIC	11.98
Roic5y	10.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.73%
Cagr1y	86.19%
Cagr3y	17.37%
Cagr5y	10.59%
Div CAGR10	13.48%
Div CAGR3	10%
Div CAGR5	10%
EPS Growth	16
EPS Growth Q	313.8
EPS Growth3 Y	-15.26
EPS Growth5 Y	-5.71
FCF Growth	-18%
FCF Growth Q	1.33%
FCF Growth3 Y	-8.54%
FCF Growth5 Y	2.57%
OCF Growth	-16.86%
OCF Growth Q	1.6%
OCF Growth10 Y	3.53%
OCF Growth3 Y	-7.43%
OCF Growth5 Y	3.23%
Revenue Growth	2.78x
Revenue Growth Q	-0.22x
Revenue Growth3 Y	-7.26x
Revenue Growth5 Y	-7.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.01
Assets	EUR 3.4B
Cash	EUR 418.2M
Current Assets	EUR 1.4B
Current Liabilities	EUR 1B
Debt	EUR 958.4M
Debt EBITDA	EUR 2.38
Debt Equity	EUR 0.58
Debt FCF	EUR 3.53
Equity	EUR 1.6B
Interest Coverage	12
Liabilities	EUR 1.7B
Long Term Assets	EUR 2B
Long Term Liabilities	EUR 709.1M
Net Cash	EUR -540.2M
Net Cash By Market Cap	EUR -11.46
Net Debt EBITDA	EUR 1.4
Net Debt Equity	EUR 0.33
Net Debt FCF	EUR 1.99
Tangible Book Value	EUR 353.9M
Tangible Book Value Per Share	EUR 1.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.36
Inventory Turnover	4.45
Net Working Capital	EUR 288.1M
Quick ratio	0.78
Working Capital	EUR 369.1M
Working Capital Turnover	EUR 7.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.06%
Dividend Growth	10.01%
Dividend Growth Years	6%
Dividend per share	EUR 0.43
Dividend Years	14
Dividend Yield	2.23%
Ex Div Date	2026-03-19
Last Dividend	EUR 0.26
Payout Frequency	Semi-Annual
Payout Ratio	64.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	44.16%
1Y total return	86.11%
200-day SMA	14.93
3Y total return	61.71%
50-day SMA	17.12
50-day SMA vs 200-day SMA	50over200
5Y total return	65.38%
All Time High	20.6
All Time High Change	-6.8%
All Time High Date	2026-05-06
All Time Low	7.51
All Time Low Change	155.66%
All Time Low Date	2020-04-06
ATR	0.72
Ch YTD	37.05
High	19.2
High52	20.6
High52 Date	2026-05-06
High52ch	-6.8%
Low	19.2
Low52	10.6
Low52 Date	2025-05-20
Low52ch	81.13%
Ma50ch	12.16%
Price vs 200-day SMA	28.58%
RSI	57.88
RSI Monthly	67.65
RSI Weekly	72
Sharpe ratio	1.15x
Sortino ratio	1.9
Total Return	6.29%
Tr YTD	39.05
Tr1m	16.65%
Tr3m	20.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 298.2M
Operating Income Growth	-6.19
Operating Income Growth Q	-11.08
Operating Income Growth3 Y	-4.89
Operating Income Growth5 Y	4.1
Operating margin	8.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	196,767,292%
Net Borrowing	54,184,771.8
Shares Insiders	0.35%
Shares Institutions	23.65%
Shares Qo Q	-3.57%
Shares Yo Y	-4.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 252.9M
Average Volume	73.35x
Bv Per Share	6.77
CAPEX	EUR -42.2M
Ch10y	15.38
Ch1m	16.65
Ch1y	81.13
Ch3m	18.37
Ch3y	48.84
Ch5y	44.58
Ch6m	30.26
Change	-0.93%
Change From Open	0
Close	19.38
Days Gap	-0.93
Depreciation Amortization	86,237,735.4
Earnings Date	2026-08-06
EBIT	EUR 298.2M
EBITDA	EUR 384.8M
EPS	EUR 0.62
F Score	6
FCF	EUR 271.5M
FCF EV Yield	5.17x
Financing CF	-257,718,780
Fiscal Year End	January
Founded	1,964
Goodwill	731,960,798.4
Graham Number	9.78017
Graham Upside	-49.06
Income Tax	EUR 22.1M
Investing CF	-53,893,620
Is Primary Listing	0
Last Earnings Date	2026-02-25
Last Report Date	2026-01-03
Lynch Fair Value	EUR 3.18
Lynch Upside	-83.44
Ma150	15.44
Ma150ch	24.33%
Ma20	17.61
Ma20ch	9.01%
Net CF	-510,840
Next Earnings Date	2026-08-06
Open	19.2
P FCF Ratio	17.36
P OCF Ratio	15.02
Payment Date	2026-04-30
Ppne	518,274,374.4
Price Date	2026-05-08
Price EBITDA	EUR 12.24
Ptbv Ratio	13.31
Relative Volume	0.04x
Revenue	3,359,964,960x
SBC By Revenue	0.55x
Share Based Comp	18,645,660
Tax By Revenue	0.66x
Tax Rate	12.38%
Tr6m	32.16%
Volume	0
Z Score	3.07

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/GL9 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$0.43 annual per share

Payout ratio

+64.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.0%

6 consecutive years of growth

Total shareholder yield

+6.3%

Next ex-dividend date: 2026-03-19

Performance

FRA/GL9 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/GL9?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.7%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-4.1%

Negative means the company is buying back shares.

Technical

FRA/GL9 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.9

Neutral momentum band

Price vs 200-day MA

+28.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/GL9

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/GL9 stock rating?

fra/GL9 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/GL9 analysis?

The full report lives at /stocks/fra/GL9/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/GL9?

The latest report frames fra/GL9 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/GL9 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.